Naftifine


Thông tin thuốc gốc
Chỉ định và Liều dùng
Topical/Cutaneous
Tinea corporis, Tinea cruris
Adult: Apply to the affected area(s) and surrounding skin as 1% cream once daily or as 1% gel bid for up to 4 weeks. As 2% cream: Apply a thin layer once daily to the affected area(s) plus 1/2 inch margin to healthy surrounding skin for 2 weeks.
Child: As 2% cream: Tinea corporis: ≥2 years Same as adult dose. Tinea cruris: ≥12 years Same as adult dose.

Topical/Cutaneous
Tinea pedis
Adult: Apply to the affected area(s) and surrounding skin as 1% cream once daily or as 1% gel bid for up to 4 weeks As 2% cream/gel: Apply a thin layer to the affected area(s) plus 1/2 inch margin of healthy surrounding skin once daily for 2 weeks.
Child: As 2% gel/cream: ≥12 years Same as adult dose.
Chống chỉ định
Hypersensitivity.
Thận trọng
Pregnancy and lactation.
Phản ứng phụ
Significant: Irritation, sensitivity.
General disorders and administration site conditions: Application site reactions.
Skin and subcutaneous tissue disorders: Burning, stinging sensation of the skin; dryness, erythema, itching.
MonitoringParameters
Perform culture and susceptibility tests or confirm diagnosis via direct microscopic examination of a KOH mounting of infected tissue; consult local institutional recommendations before treatment initiation due to antifungal resistance risks. Monitor for signs of application site reactions (e.g. exfoliation, erythema, dermatitis).
Tác dụng
Description: Naftifine is a synthetic allylamine with fungistatic and fungicidal activity. It inhibits squalene 2, 3-epoxidase which causes a decrease in ergosterol synthesis and consequently an increase in squalene cells.
Pharmacokinetics:
Absorption: Systemically absorbed after topical application.
Excretion: Via urine and faeces (as unchanged drug and metabolites). Elimination half-life: 2-3 days.
Đặc tính

Chemical Structure Image
Naftifine

Source: National Center for Biotechnology Information. PubChem Compound Summary for CID 47641, Naftifine. https://pubchem.ncbi.nlm.nih.gov/compound/Naftifine. Accessed Mar. 26, 2021.

Bảo quản
Store between 20-25°C. Storage recommendations may vary among individual products. Refer to specific product guidelines.
Phân loại ATC
D01AE22 - naftifine ; Belongs to the class of other antifungals for topical use.
References
Anon. Naftifine. AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. https://www.ahfscdi.com. Accessed 05/03/2021.

Anon. Naftifine. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 05/03/2021.

Buckingham R (ed). Naftifine Hydrochloride. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 05/03/2021.

Exoderil Cream (P&G Health Austria GmbH & Co. OG). National Pharmaceutical Regulatory Agency - Ministry of Health Malaysia. https://www.npra.gov.my. Accessed 05/03/2021.

Naftifine Hydrochloride Cream (Tolmar, Inc.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed. Accessed 05/03/2021.

Naftifine Hydrochloride Gel (Tolmar, Inc.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed. Accessed 05/03/2021.

Naftin Cream (Merz Pharmaceuticals). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed. Accessed 05/03/2021.

Naftin Gel (Sebela Pharmaceuticals Inc.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed. Accessed 08/03/2021.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Naftifine từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2021 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in